PentaBase is a knowledge-based Danish pharmacogenomics located in Odense. The company specializes in molecular diagnostics assays for real-time PCR, with focus on detection of somatic mutations in cancer. Besides this, PentaBase offers oligonucleotide production and, since March 2020, it produces multiplex assays for COVID-19 detection on real-time PCR.
For more than 10 years, PentaBase has created products for researchers and medical professionals exploring new treatments and helping patients worldwide.
“We believe in open-platform designs and strive to make our products compatible with basic instruments used in molecular biology facilities around the world.” – Ulf Bech Christensen, CEO